MetaCap

Ardent Health Inc. (ARDT)

NYSE: ARDTHealth CareHospital/Nursing ManagementUSD

15.08+0.58 (+4.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ARDT stock chart

Technical analysis

Key statistics

All statistics
52-week range
7.71 – 18.57
Day range
14.35 – 15.16
Volume / Avg
1.54M / 719.06K
Beta
—

52-week range

$7.71$18.57

ARDT stock today

Shares of Ardent Health (ARDT) finished higher on Nov 20 at $15.08, a gain of 4.00% or $0.58 per share, versus the S&P 500's 3.70% decline. Volume was 2.1x the average at 1.54M shares, a sign of unusually heavy trading. Shares are 18.8% below their 52-week high of $18.57, set on Nov 9, 2026 and 95.6% above the 52-week low of $7.71, in the middle of the past year's range.

ARDT is up 70.8% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 68.7%. At 14.6x trailing earnings, Ardent Health trades below the peer-group median of 16.7x. Its forward P/E of 10.9x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Ardent Health

Company profile

Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings.

Industry
Hospital/Nursing Management
CEO
Mr. David Caspers
Headquarters
Brentwood, TN
Employees
19,500
IPO year
2024

Financial highlights

Full financials

In fiscal 2025, Ardent Health generated $6.32 billion in revenue, up 6.0% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $135.8 million (-35.4% year over year), for a net margin of 2.1% versus a median of 3.5% in the prior 3 years. Diluted earnings per share came in at $0.96, down from $1.58.

Ardent Health annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022
Revenue$6.32B$5.97B$5.41B$5.13B
Growth+6.01%+10.29%+5.45%—
Net income$135.81M$210.34M$53.90M$188.91M
EPS (diluted)$0.96$1.58$0.43$1.50

Analyst forecast

Forecast

Consensus (13 analysts)

buy

Avg. price target

$17.38+15.25%

  • Strong buy 1
  • Buy 6
  • Hold 5
  • Sell 0
  • Strong sell 1

Target range

Low $12.00High $22.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 4, 2026
EPS actual vs est.
$0.52 vs $0.24
Surprise
+116.67%

ARDT news

All ARDT news

Ardent Health peers

Health Care sector
ARDT peer companies
CompanyPrice% ChgMarket capCompare
BKDBrookdale Senior Living Inc.8.86+1.96%$2.12Bvs ARDT
MDPediatrix Medical Group Inc.30.22+0.94%$2.36Bvs ARDT
HCSGHealthcare Services Group Inc.24.72-0.20%$1.67Bvs ARDT
SNDASonida Senior Living Inc.31.47-0.57%$1.55Bvs ARDT
NHCNational HealthCare Corporation190.77+1.18%$2.99Bvs ARDT
SGRYSurgery Partners Inc.26.78+0.34%$3.50Bvs ARDT
CYHCommunity Health Systems Inc.1.62+0.62%$228.46Mvs ARDT
PACSPACS Group Inc.43.67+1.49%$6.93Bvs ARDT

Indexes, lists and sector

Ardent Health stock FAQ

What is Ardent Health's stock price today?

ARDT last traded at $15.08 as of Nov 20, 4:00 PM EST, up 4.00% on the day. Prices are delayed at least 15 minutes.

What is ARDT's P/E ratio?

ARDT trades at a trailing P/E ratio of 14.64 and a forward P/E of 10.91, compared with a median of 16.7 for its closest peers.

Who is Ardent Health's CEO?

Mr. David Caspers is the chief executive officer of Ardent Health Inc., which has about 19,500 employees.

What is the ARDT 52-week high?

The 52-week high for ARDT is $18.57 and the 52-week low is $7.71. The stock is currently 18.8% below its high.

Compare ARDT